These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 35426922)

  • 21. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.
    Tosto G; Zimmerman ME; Carmichael OT; Brickman AM;
    JAMA Neurol; 2014 Jul; 71(7):872-7. PubMed ID: 24821476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
    Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
    J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
    Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
    Scharf EL; Graff-Radford J; Przybelski SA; Lesnick TG; Mielke MM; Knopman DS; Preboske GM; Schwarz CG; Senjem ML; Gunter JL; Machulda M; Kantarci K; Petersen RC; Jack CR; Vemuri P
    Stroke; 2019 Nov; 50(11):3037-3044. PubMed ID: 31510903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective associations between white matter hyperintensities and lower extremity function.
    Moon SY; de Souto Barreto P; Rolland Y; Chupin M; Bouyahia A; Fillon L; Mangin JF; Andrieu S; Cesari M; Vellas B;
    Neurology; 2018 Apr; 90(15):e1291-e1297. PubMed ID: 29523640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-Sectional Association Between Cognitive Frailty and White Matter Hyperintensity Among Memory Clinic Patients.
    Sugimoto T; Ono R; Kimura A; Saji N; Niida S; Toba K; Sakurai T
    J Alzheimers Dis; 2019; 72(2):605-612. PubMed ID: 31594230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders.
    Kim YE; Lim JS; Suh CH; Heo H; Roh JH; Cheong EN; Lee Y; Kim JW; Lee JH
    Alzheimers Res Ther; 2024 Aug; 16(1):185. PubMed ID: 39148136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Burden Moderates the Relationship Between ADHD and Cognition in Older Adults.
    Callahan BL; Becker S; Ramirez J; Taylor R; Shammi P; Gao F; Black SE
    Am J Geriatr Psychiatry; 2024 Apr; 32(4):427-442. PubMed ID: 37989710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm.
    Tubi MA; Feingold FW; Kothapalli D; Hare ET; King KS; Thompson PM; Braskie MN;
    Neuroimage; 2020 Feb; 206():116327. PubMed ID: 31682983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tract-defined regional white matter hyperintensities and memory.
    Rizvi B; Lao PJ; Colón J; Hale C; Igwe KC; Narkhede A; Budge M; Manly JJ; Schupf N; Brickman AM
    Neuroimage Clin; 2020; 25():102143. PubMed ID: 31887716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Obstructive Sleep Apnea and Brain White Matter Hyperintensities in a Population-Based Cohort in Germany.
    Zacharias HU; Weihs A; Habes M; Wittfeld K; Frenzel S; Rashid T; Stubbe B; Obst A; Szentkirályi A; Bülow R; Berger K; Fietze I; Penzel T; Hosten N; Ewert R; Völzke H; Grabe HJ
    JAMA Netw Open; 2021 Oct; 4(10):e2128225. PubMed ID: 34609493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive impairment risk: white matter hyperintensity progression matters.
    Silbert LC; Howieson DB; Dodge H; Kaye JA
    Neurology; 2009 Jul; 73(2):120-5. PubMed ID: 19597134
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between white matter hyperintensity volume and cognitive/physical decline in older people with dementia: A one-year longitudinal study.
    Hairu R; Close JCT; Lord SR; Delbaere K; Wen W; Jiang J; Taylor ME
    Aging Ment Health; 2022 Dec; 26(12):2503-2510. PubMed ID: 34569854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.